Inari Medical Stock Today
| NARI Stock | USD 49.66 0.09 0.18% |
Performance6 of 100
| Odds Of DistressLess than 21
|
Inari Medical is trading at 49.66 as of the 23rd of November 2024. This is a 0.18 percent decrease since the beginning of the trading day. The stock's open price was 49.75. Inari Medical has about a 21 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Inari Medical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of December 2022 and ending today, the 23rd of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 22nd of May 2020 | Category Healthcare | Classification Health Care |
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. The company has 58.54 M outstanding shares of which 3.69 M shares are now shorted by private and institutional investors with about 3.79 trading days to cover. More on Inari Medical
Moving against Inari Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Inari Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, SP Small-Cap 600, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsInari Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Inari Medical's financial leverage. It provides some insight into what part of Inari Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inari Medical (NARI) is traded on NASDAQ Exchange in USA. It is located in 6001 Oak Canyon, Irvine, CA, United States, 92618 and employs 1,300 people. Inari Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.91 B. Inari Medical conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 58.54 M outstanding shares of which 3.69 M shares are now shorted by private and institutional investors with about 3.79 trading days to cover.
Inari Medical currently holds about 330.5 M in cash with 35.93 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.19.
Check Inari Medical Probability Of Bankruptcy
Ownership AllocationInari Medical has a total of 58.54 Million outstanding shares. The majority of Inari Medical outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Inari Medical to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Inari Medical. Please pay attention to any change in the institutional holdings of Inari Medical as this could imply that something significant has changed or is about to change at the company. Also note that almost two million three hundred seventy-one thousand fourty invesors are currently shorting Inari Medical expressing very little confidence in its future performance.
Check Inari Ownership Details
Inari Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Jpmorgan Chase & Co | 2024-06-30 | 1.2 M | |
| Armistice Capital, Llc | 2024-06-30 | 1 M | |
| American Century Companies Inc | 2024-09-30 | 979.4 K | |
| Mackenzie Investments | 2024-09-30 | 853.8 K | |
| Manufacturers Life Insurance Co | 2024-09-30 | 795.1 K | |
| Bamco Inc | 2024-06-30 | 777.2 K | |
| Fuller & Thaler Asset Management Inc | 2024-09-30 | 768.5 K | |
| Bank Of America Corp | 2024-06-30 | 667.2 K | |
| Dimensional Fund Advisors, Inc. | 2024-09-30 | 658 K | |
| Blackrock Inc | 2024-06-30 | 8.4 M | |
| Vanguard Group Inc | 2024-09-30 | 5.6 M |
Inari Medical Historical Income Statement
Inari Stock Against Markets
Inari Medical Corporate Management
| Angela JD | General Secretary | Profile | |
| Tara Dunn | Senior Development | Profile | |
| John Borrell | Senior Sales | Profile | |
| Kevin Strange | Accounting, Finance | Profile | |
| Janet Byk | VP Accounting | Profile | |
| John CFA | Vice Relations | Profile | |
| Tim Benner | Senior Sales | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Inari Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inari Medical. If investors know Inari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inari Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.84) | Earnings Share (1.35) | Revenue Per Share 9.901 | Quarterly Revenue Growth 0.214 | Return On Assets (0.03) |
The market value of Inari Medical is measured differently than its book value, which is the value of Inari that is recorded on the company's balance sheet. Investors also form their own opinion of Inari Medical's value that differs from its market value or its book value, called intrinsic value, which is Inari Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inari Medical's market value can be influenced by many factors that don't directly affect Inari Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inari Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inari Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inari Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.